TY - JOUR
T1 - Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease
AU - Dweck, Marc R.
AU - Williams, Michelle C.
AU - Moss, Alastair J.
AU - Newby, David E.
AU - Fayad, Zahi A.
N1 - Publisher Copyright:
© 2016 The Authors
PY - 2016/11/15
Y1 - 2016/11/15
N2 - Ischemic heart disease is a complex disease process caused by the development of coronary atherosclerosis, with downstream effects on the left ventricular myocardium. It is characterized by a long preclinical phase, abrupt development of myocardial infarction, and more chronic disease states such as stable angina and ischemic cardiomyopathy. Recent advances in computed tomography (CT) and cardiac magnetic resonance (CMR) now allow detailed imaging of each of these different phases of the disease, potentially allowing ischemic heart disease to be tracked during a patient's lifetime. In particular, CT has emerged as the noninvasive modality of choice for imaging the coronary arteries, whereas CMR offers detailed assessments of myocardial perfusion, viability, and function. The clinical utility of these techniques is increasingly being supported by robust randomized controlled trial data, although the widespread adoption of cardiac CT and CMR will require further evidence of clinical efficacy and cost effectiveness.
AB - Ischemic heart disease is a complex disease process caused by the development of coronary atherosclerosis, with downstream effects on the left ventricular myocardium. It is characterized by a long preclinical phase, abrupt development of myocardial infarction, and more chronic disease states such as stable angina and ischemic cardiomyopathy. Recent advances in computed tomography (CT) and cardiac magnetic resonance (CMR) now allow detailed imaging of each of these different phases of the disease, potentially allowing ischemic heart disease to be tracked during a patient's lifetime. In particular, CT has emerged as the noninvasive modality of choice for imaging the coronary arteries, whereas CMR offers detailed assessments of myocardial perfusion, viability, and function. The clinical utility of these techniques is increasingly being supported by robust randomized controlled trial data, although the widespread adoption of cardiac CT and CMR will require further evidence of clinical efficacy and cost effectiveness.
KW - acute coronary syndrome
KW - atherosclerosis
KW - calcium
KW - coronary artery disease
KW - myocardial infarction
KW - noninvasive imaging
UR - https://www.scopus.com/pages/publications/85006272391
U2 - 10.1016/j.jacc.2016.08.047
DO - 10.1016/j.jacc.2016.08.047
M3 - Review article
C2 - 27855810
AN - SCOPUS:85006272391
SN - 0735-1097
VL - 68
SP - 2201
EP - 2216
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 20
ER -